nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Arthropathy—Dexamethasone—ankylosing spondylitis	0.00661	0.00661	CcSEcCtD
Deferiprone—Arthropathy—Betamethasone—ankylosing spondylitis	0.00661	0.00661	CcSEcCtD
Deferiprone—Glycosuria—Prednisone—ankylosing spondylitis	0.00646	0.00646	CcSEcCtD
Deferiprone—Arthropathy—Prednisone—ankylosing spondylitis	0.00575	0.00575	CcSEcCtD
Deferiprone—Increased appetite—Prednisolone—ankylosing spondylitis	0.00556	0.00556	CcSEcCtD
Deferiprone—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.00523	0.00523	CcSEcCtD
Deferiprone—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Deferiprone—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00511	0.00511	CcSEcCtD
Deferiprone—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Deferiprone—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.00481	0.00481	CcSEcCtD
Deferiprone—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.0048	0.0048	CcSEcCtD
Deferiprone—Increased appetite—Betamethasone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Deferiprone—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Deferiprone—Sepsis—Prednisone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Deferiprone—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Deferiprone—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Deferiprone—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Deferiprone—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Deferiprone—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Deferiprone—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Deferiprone—Weight increased—Prednisolone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Deferiprone—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Deferiprone—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Deferiprone—Increased appetite—Prednisone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Deferiprone—Cardiac failure—Prednisone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Deferiprone—Osteoarthritis—Prednisone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Deferiprone—Sepsis—Methotrexate—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Deferiprone—Weight increased—Triamcinolone—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Deferiprone—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Deferiprone—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Deferiprone—Infestation—Methylprednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Deferiprone—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Deferiprone—Weight increased—Dexamethasone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Deferiprone—Weight increased—Betamethasone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Deferiprone—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Deferiprone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Deferiprone—Pancreatitis—Prednisone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Deferiprone—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Deferiprone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Deferiprone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Deferiprone—Neutropenia—Prednisone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Deferiprone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Deferiprone—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Deferiprone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Deferiprone—Weight increased—Prednisone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Deferiprone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Deferiprone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Deferiprone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Deferiprone—Eye disorder—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Deferiprone—Back pain—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Deferiprone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Deferiprone—Angiopathy—Betamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Deferiprone—Convulsion—Prednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Deferiprone—Hypertension—Prednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Deferiprone—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Deferiprone—Discomfort—Prednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Deferiprone—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Deferiprone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Deferiprone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Deferiprone—Neutropenia—Methotrexate—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Deferiprone—Convulsion—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Deferiprone—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Deferiprone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Deferiprone—Hypertension—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Deferiprone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Deferiprone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Deferiprone—Pneumonia—Methotrexate—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Deferiprone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Deferiprone—Eye disorder—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Deferiprone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Deferiprone—Infestation—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Deferiprone—Discomfort—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Deferiprone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Deferiprone—Angiopathy—Prednisone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Deferiprone—Immune system disorder—Prednisone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Deferiprone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Deferiprone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Deferiprone—Infection—Triamcinolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Deferiprone—Infection—Methylprednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Deferiprone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Deferiprone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Deferiprone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Deferiprone—Mental disorder—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Deferiprone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Deferiprone—Malnutrition—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Deferiprone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Deferiprone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Deferiprone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Deferiprone—Convulsion—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Deferiprone—Convulsion—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Deferiprone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Deferiprone—Hypertension—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Deferiprone—Discomfort—Dexamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Deferiprone—Discomfort—Betamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Deferiprone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Deferiprone—Pain—Prednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Deferiprone—Hepatitis—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Deferiprone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Deferiprone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Deferiprone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Deferiprone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Deferiprone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Deferiprone—Infection—Dexamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Deferiprone—Infection—Betamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Deferiprone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Deferiprone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Deferiprone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Deferiprone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Deferiprone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Deferiprone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Deferiprone—Eye disorder—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Deferiprone—Urticaria—Prednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Deferiprone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Deferiprone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Deferiprone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Deferiprone—Pain—Triamcinolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Deferiprone—Hypotension—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Deferiprone—Hypotension—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Deferiprone—Angiopathy—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Deferiprone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Deferiprone—Convulsion—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Deferiprone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Deferiprone—Hypertension—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Deferiprone—Chills—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Deferiprone—Arthralgia—Prednisone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Deferiprone—Discomfort—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Deferiprone—Mental disorder—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Deferiprone—Malnutrition—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Deferiprone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Deferiprone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Deferiprone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Deferiprone—Urticaria—Triamcinolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Deferiprone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Deferiprone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Deferiprone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Deferiprone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Deferiprone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Deferiprone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Deferiprone—Infection—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Deferiprone—Back pain—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Deferiprone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Deferiprone—Fatigue—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Deferiprone—Pain—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Deferiprone—Pain—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Deferiprone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Deferiprone—Skin disorder—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Deferiprone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Deferiprone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Deferiprone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Deferiprone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Deferiprone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Deferiprone—Urticaria—Betamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Deferiprone—Urticaria—Dexamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Deferiprone—Asthenia—Triamcinolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Deferiprone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Deferiprone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Deferiprone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Deferiprone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Deferiprone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Deferiprone—Pruritus—Triamcinolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Deferiprone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Deferiprone—Convulsion—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Deferiprone—Dyspepsia—Prednisone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Deferiprone—Arthralgia—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Deferiprone—Decreased appetite—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Deferiprone—Rash—Prednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Deferiprone—Dermatitis—Prednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Deferiprone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Deferiprone—Fatigue—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Deferiprone—Headache—Prednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Deferiprone—Discomfort—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Deferiprone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Deferiprone—Infection—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Deferiprone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Deferiprone—Asthenia—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Deferiprone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Deferiprone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Deferiprone—Nausea—Prednisolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Deferiprone—Pruritus—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Deferiprone—Pruritus—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Deferiprone—Skin disorder—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Deferiprone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Deferiprone—Vomiting—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Deferiprone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Deferiprone—Rash—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Deferiprone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Deferiprone—Rash—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Deferiprone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Deferiprone—Urticaria—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Deferiprone—Headache—Triamcinolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Deferiprone—Headache—Methylprednisolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Deferiprone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Deferiprone—Body temperature increased—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Deferiprone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Deferiprone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Deferiprone—Hypotension—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Deferiprone—Nausea—Triamcinolone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Deferiprone—Nausea—Methylprednisolone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Deferiprone—Somnolence—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Deferiprone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Deferiprone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Deferiprone—Vomiting—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Deferiprone—Vomiting—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Deferiprone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Deferiprone—Rash—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Deferiprone—Rash—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Deferiprone—Dermatitis—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Deferiprone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Deferiprone—Fatigue—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Deferiprone—Headache—Dexamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Deferiprone—Headache—Betamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Deferiprone—Asthenia—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Deferiprone—Pain—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Deferiprone—Pruritus—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Deferiprone—Diarrhoea—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Deferiprone—Nausea—Betamethasone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Deferiprone—Nausea—Dexamethasone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Deferiprone—Urticaria—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Deferiprone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Deferiprone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Deferiprone—Vomiting—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Deferiprone—Rash—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Deferiprone—Dermatitis—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Deferiprone—Headache—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Deferiprone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Deferiprone—Asthenia—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Deferiprone—Nausea—Prednisone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Deferiprone—Pruritus—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Deferiprone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Deferiprone—Vomiting—Methotrexate—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Deferiprone—Rash—Methotrexate—ankylosing spondylitis	0.000984	0.000984	CcSEcCtD
Deferiprone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000983	0.000983	CcSEcCtD
Deferiprone—Headache—Methotrexate—ankylosing spondylitis	0.000978	0.000978	CcSEcCtD
Deferiprone—Nausea—Methotrexate—ankylosing spondylitis	0.000927	0.000927	CcSEcCtD
